(Q37700000)

22 August 2017

1 reference

title

Assessment and management of fatigue in neuromuscular disease (English)

1 reference

22 August 2017

3

Gregory T Carter

1 reference

22 August 2017

Jau-Shin Lou

1

1 reference

22 August 2017

Michael D Weiss

series ordinal

2

1 reference

22 August 2017

language of work or name

1 reference

1 March 2010

1 reference

American Journal of Hospice and Palliative Medicine

22 August 2017

published in

1 reference

22 August 2017

volume

27

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

145-157

1 reference

Amyotrophic lateral sclerosis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Fatigue and depression are associated with poor quality of life in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Fatigue in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Approaching fatigue in neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Resilience and distress among amyotrophic lateral sclerosis patients and caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

The importance of assessing quality of life in patients with neuromuscular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Correlates of suffering in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Improving the quality of life for people with ALS: the challenge ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Measurement of human muscle fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Dissociation between mechanical and myoelectrical manifestation of muscle fatigue in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Interpretation of EMG changes with fatigue: facts, pitfalls, and fallacies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Physiology of fatigue in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Central fatigue during isometric exercise in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Quality of life in ALS depends on factors other than strength and physical function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Chronic pain in persons with neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Evaluation of phrenic nerve and pulmonary function in hereditary motor and sensory neuropathy, type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Sleep-disordered breathing in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Pursed lips breathing improves ventilation in myotonic muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Obesity, physical activity, and the metabolic syndrome in adult neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Metabolic syndrome in neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Response to aerobic exercise training in humans with neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

A randomized controlled trial of resistance exercise in individuals with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Rehabilitation management of neuromuscular disease: the role of exercise training

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Effect of voluntary wheel-running exercise on muscles of the mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Adaptations to exercise training and contraction-induced muscle injury in animal models of muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Modafinil for excessive daytime sleepiness in myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Modafinil prevents glutamate cytotoxicity in cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Electroencephalographic effects of modafinil, an alpha-1-adrenergic psychostimulant, on the sleep of rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Antifatigue effects of coenzyme Q10 during physical fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Effect of caffeine on the neuromuscular system--potential as an ergogenic aid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Clinical use of creatine in neuromuscular and neurometabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Metabolic myopathies: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

A review of nutrition in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Endurance training improves fitness and strength in patients with Becker muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Strength training and albuterol in facioscapulohumeral muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

The potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Noninvasive ventilation in ALS: indications and effect on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Evaluation of the cardiomyopathy in becker muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909109358420

21 January 2018

Identifiers

DOI

10.1177/1049909109358420

1 reference

22 August 2017

1 reference